NumFin

Jiang Zhong Pharmaceutical Co.,Ltd

Symboli: 600750.SS

SHH

27.05

CNY

Markkinahinta tänään

  • 23.0341

    P/E-suhde

  • 1.6311

    PEG-suhde

  • 16.91B

    MRK Cap

  • 0.05%

    DIV Tuotto

Jiang Zhong Pharmaceutical Co.,Ltd (600750-SS) Tilinpäätöstiedotteet

Download
VuosittainenNeljännesvuosittain
LineaarinenLog
Kaaviossa näet oletusarvot Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS). Yrityksen liikevaihto näyttää NaN M keskiarvon, joka on NaN % gowth. Koko jakson keskimääräinen bruttovoitto on NaN M, joka on NaN %. Keskimääräinen bruttovoittosuhde on NaN %. Yrityksen viime vuoden tuloksen nettotuloksen kasvu on NaN %, joka on NaN % % keskimäärin koko yrityksen historian aikana.,

VuosittainenNeljännesvuosittain
10Y20Y30Y40Y

Tase

Jiang Zhong Pharmaceutical Co.,Ltd verotukselliseen kehitykseen sukeltamalla havaitsemme keskimääräisen varallisuuden kasvun. Tämä korko on mielenkiintoisesti , mikä heijastaa sekä yrityksen huippuja että matalimpia lukemia. Neljännesvuosittaisessa vertailussa tämä luku on . Kun tarkastellaan viime vuotta taaksepäin, kokonaisvarojen muutos on NaN. Osakkeenomistajien arvo, jota kuvaa osakepääoman kokonaismäärä, arvostetaan NaN raportointivaluutassa. Tämän näkökohdan vuosittainen muutos on NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

balance-sheet.row.cash-and-short-term-investments

01382.92744.22773.8
2080.9
1581.4
1014.6
724.8
898
250.4
605.5
711.2
957.1
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
117.4
190.2
266.8
240.2
155.2
30.9
59.7
122.4
4.3
2.3
4.9

balance-sheet.row.short-term-investments

0501372.81727.7
980.9
654.1
-1.1
-0.6
-0.6
-0.7
-5
-11.5
-0.9
-1.2
-1.4
0
0
0
0
0
0
0.8
0
0
10
0
0
10
0
0
0
0

balance-sheet.row.net-receivables

0562.8872.5893.1
929.3
1181.2
1005.1
895.4
530.7
789.3
1008.6
700
625.3
669.5
575.1
382.7
536.6
248.3
361.2
172.6
246.1
226.2
141.6
187.6
6.3
3
164.7
110.1
33.6
0
0
0

balance-sheet.row.inventory

0406.2382.2378
246.7
242.5
171.8
194.4
187.5
158.4
312.8
334.9
344.2
293.7
278.6
117.8
100.6
108.7
97.1
87.9
71.9
72.1
81.7
43.6
49.1
71.3
52.7
65.1
71.2
19.7
13.4
9.5

balance-sheet.row.other-current-assets

045.223.219.6
18.3
56.6
102.2
153.4
130.8
170.9
162.7
-7.4
-8.1
-58.6
-69.2
-69.9
-152.7
0.1
0.3
-16.8
0
0.4
0.7
-29.9
185.2
227
-33.5
-15.8
-2.5
0
0
0

balance-sheet.row.total-current-assets

02397.14022.14064.5
3275.2
3061.7
2293.7
1968
1747.2
1368.9
2089.6
1738.7
1918.6
1442.6
1533.5
695.3
615.1
469.8
527.7
327.2
362.4
416.1
414.2
468.2
480.8
456.5
214.8
219.1
224.8
42.9
25.9
24.3

balance-sheet.row.property-plant-equipment-net

01597.515201220.4
1021.6
1062.9
954.5
843.8
722.2
718.6
749.1
798.1
843.7
664.2
504.3
458.2
494.8
579.3
636.4
658.5
630.1
486.3
245
165.1
202.2
195.2
179.8
165.5
91.8
64.7
57.3
51.5

balance-sheet.row.goodwill

041.741.741.7
14.8
14.8
0
0
0
0
0
0
0
0
0
0
0
0
2.3
3
3.8
4.6
5.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0401.1379.1395.5
377.8
360
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
89.8
98.8
98.5
8.8
4.7
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0442.8420.8437.3
392.6
374.8
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
92.1
101.9
102.3
13.4
10.1
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.long-term-investments

0112.9-1197.9-1568.9
-824.3
-435.8
194.1
187.2
204.1
192.6
63.1
68.7
65.8
65.4
67.5
67.9
68.2
0
0
0
0
69.1
0
0
12.8
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

060.444.444.9
39
37
26
27.2
16.4
10.4
11.7
10.4
12.1
10.8
14.6
11.7
25.6
7.5
0
0
0
1.6
0
0
-12.6
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01517.81434.21799.4
1019.5
658.5
33.2
12.2
39.7
39.1
39.1
5.1
5.1
2.8
2.4
1.6
0.6
85.7
62.3
63.8
69.7
0.6
71.5
1.6
20.8
23.7
23.9
24.6
7.2
0
0
0

balance-sheet.row.total-non-current-assets

03731.42221.61933.1
1648.4
1697.5
1523.2
1396.1
1318.6
1309.4
1237.4
1253.7
1310.3
1146.3
972.5
902.3
971.1
752.1
790.8
824.1
802.1
570.9
326.6
171.1
227.7
221
206.4
192.9
99
64.7
57.3
51.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.account-payables

0118.4236.3205.7
45.6
56.3
119.5
88.1
47.7
45.1
308.5
231.9
229.6
249.5
212.6
95.4
46.9
64
119.3
61.6
72.1
65.2
46.5
37.8
34.7
54.4
56.1
43
16.5
8.8
3.8
1.5

balance-sheet.row.short-term-debt

055.621.7
0.1
-112
20
0
30
20
125
25
200
200
225
174
364
274.1
343.1
342.4
270
125.8
59.5
22
18.1
36.3
10
10.8
10
7.2
2
3.1

balance-sheet.row.tax-payables

048.173.948.9
38.4
64.5
86.3
44.7
49.8
20.1
12.1
-55.9
11.8
4
50.4
24.3
32.7
3.2
12
10.5
3.1
31.2
-3.9
1.7
62.5
21.8
-1.2
1
3.1
3
1.7
5.2

balance-sheet.row.long-term-debt-total

011.22.8
0.2
0
50
70
0
0
498.2
496.6
525
0
0
80
0
0
0
0
127.4
36.7
0
0
13
25
53
53
53
49.3
30
30

Deferred Revenue Non Current

048.967.873
50.6
58.1
59.8
48.7
24.3
0.9
12.5
12.7
0
0
0
0
0
0
0
0
0
0
0
0
-13
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01119.91070.8809.2
386.8
692.6
227.8
241.9
224.1
155.2
125.3
81.3
100.1
119
151
77.8
125.1
18.9
65.3
7.9
10.3
38.7
5.9
3.8
3.2
15
12.8
13.8
24.9
5.1
13.1
9.6

balance-sheet.row.total-non-current-liabilities

018.590.698.6
70.8
85.9
109.8
118.7
24.4
1.1
510.9
509.3
538
12.4
3.5
83.5
2.5
0.2
0.2
0.2
127.6
65.8
26.4
0
14.1
25
53
53
53
49.3
30
30

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011.22.8
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01604.51748.31415.1
672.3
834.8
563.5
448.7
450
323.7
1193.9
859.1
1175.8
671.1
726.9
524.7
616.7
383.9
569.9
449.2
501.7
347.1
165.6
88.2
162.7
161.5
143.4
166.5
104.4
70.3
48.9
44.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0629.4629.6630
630
525
420
300
300
300
300
311.1
311.1
311.1
311.1
295.9
295.9
295.9
146.1
146.1
146.1
146.1
146.1
146.1
146.1
146.1
124.8
124.8
62.4
27.9
27.9
27.9

balance-sheet.row.retained-earnings

02437.32524.12652.1
2503.9
2339.6
2182.4
1893
1595.3
1335.5
1058.5
883.6
804.7
672.7
559.8
411.8
329.2
252.3
220.3
180.7
153.6
133.6
92.6
61.6
71.8
76.5
52.4
26.7
12.1
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0433.4430.1421
371
324.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0331.5307.1300
372
372
650.9
722.2
720.3
718.8
718.8
884.6
884.6
882.7
861.2
318.9
296.1
288.7
380.7
373.2
360.4
322.5
311
315.9
305.3
293.5
100.6
93.9
144.9
9.4
6.4
3.7

balance-sheet.row.total-stockholders-equity

03831.538914003
3876.9
3560.6
3253.3
2915.2
2615.5
2354.3
2077.3
2079.3
2000.4
1866.6
1732.1
1026.6
921.2
836.8
747.1
700
660.1
602.2
549.7
523.6
523.2
516.1
277.9
245.5
219.4
37.3
34.4
31.7

balance-sheet.row.total-liabilities-and-stockholders-equity

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.minority-interest

0643.6604.4579.5
374.4
363.7
0.1
0.2
0.2
0.2
55.8
53.9
52.6
51.1
47
46.3
48.2
1.1
1.5
2.1
2.8
37.6
25.5
27.5
22.6
0
0
0
0
0
0
0

balance-sheet.row.total-equity

04475.14495.44582.5
4251.3
3924.4
3253.4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0162.9174.9158.8
156.6
218.3
192.9
186.6
203.4
191.9
58.1
57.2
64.9
64.2
66.1
67.9
68.2
85.7
62.3
63.8
69.3
69.9
70.8
0.1
22.8
23.7
23.8
10
0
0
0
0

balance-sheet.row.total-debt

056.63.24.5
0.3
0
20
70
30
20
623.2
521.6
725
200
225
254
364
274.1
343.1
342.4
397.4
162.5
59.5
22
31.1
61.3
63
63.8
63
56.5
32
33.1

balance-sheet.row.net-debt

0-1276.3-1368.2-1041.6
-1099.7
-927.3
-994.6
-654.8
-868
-230.4
17.7
-189.6
-232.1
-337.9
-523.9
-10.8
233.4
161.5
273.9
258.8
353
45.9
-130.7
-244.8
-199.1
-93.9
32.1
14
-59.4
52.2
29.7
28.2

Kassavirtalaskelma

Jiang Zhong Pharmaceutical Co.,Ltd taloudessa on tapahtunut huomattava muutos vapaan kassavirran määrässä viimeisen ajanjakson aikana, ja se on muuttunut NaN suuntaan. Yhtiö on hiljattain laajentanut osakepääomaansa laskemalla liikkeeseen NaN, mikä merkitsee NaN eroa edelliseen vuoteen verrattuna. Yhtiön investointitoiminnasta aiheutui nettokassan käyttöä, joka oli NaN raportointivaluutassa. Tämä on NaN siirtymä edellisestä vuodesta. Samana ajanjaksona yhtiö kirjasi NaN, NaN ja NaN, jotka ovat merkittäviä yrityksen investointi-ja takaisinmaksustrategioiden ymmärtämisen kannalta. Yhtiön rahoitustoiminta johti siihen, että nettokassan käyttö oli NaN, ja ero edellisvuoteen oli {{year_over_year_net_cash_from_financing_activities_change_percentage}}. Lisäksi yhtiö osoitti NaN osingonjakoon osakkeenomistajilleen. Samaan aikaan se toteutti myös muita rahoitusmanöövereitä, joihin viitataan nimellä {{other-financing-activities}}, jotka myös vaikuttivat merkittävästi sen kassavirtaan kyseisenä ajanjaksona. Nämä osatekijät muodostavat yhdessä kattavan kuvan yrityksen taloudellisesta tilanteesta ja strategisesta lähestymistavasta kassavirran hallintaan.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0708.3644.2530.9
490.3
479.4
470.2
417.7
379.8
368
266.8
173.5
226.9
232
261.8
199.2
129.5
96.1
75.7
52.9
43.6
62.8
38.7
47.7
31.7
37.4
33.7

cash-flows.row.depreciation-and-amortization

0122.3121.9115.4
112.8
113
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5

cash-flows.row.deferred-income-tax

0-13.1-0.7-6.2
-9.6
-0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-83.110.76.2
9.6
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0161.5312.4330.2
131.7
77.3
-41.3
-353.2
256.8
24.1
-85.8
-161.6
-103.2
-120.6
-127.1
68.6
53.4
-40.1
-121.2
45.4
-96.7
-29.4
32.1
-35.7
80
-96.7
-44.7

cash-flows.row.account-receivables

0291.527.4159.5
240.6
42.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-28.1-4.3-23.6
-6.5
1.9
18.5
-3.4
-24.6
-23.9
-16.6
9.4
-50
-11.2
-164.1
-23.9
7.9
-15.1
-9.4
-20.4
-2.7
0.8
-26.9
5.1
22.8
-17.9
12.3

cash-flows.row.account-payables

0-101.8290200.5
-92.8
33.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-0.7-6.2
-9.6
-0.8
-59.8
-349.8
281.4
48
-69.1
-171
-53.1
-109.4
37.1
92.5
45.5
-24.9
-111.8
65.8
-94
-30.2
59
-40.8
57.2
-78.8
-57

cash-flows.row.other-non-cash-items

0182-72.6-59.5
17.8
-28.6
-15.2
-2.4
-4.3
50.8
92.7
6.1
26.5
-10.5
17.3
45.7
26.2
37.2
37.6
41.3
36.7
21
2.9
14
-2.3
22.4
-10

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.acquisitions-net

0-13.20.11.2
183.2
131.2
0.7
1.1
2.3
14.5
0.1
0
0
0
0
0
-289
0.2
0
0
0.2
0.1
0
14.6
27.3
0
0

cash-flows.row.purchases-of-investments

0-1840.5-3260.4-5196.8
-3459
-2695.4
-13.5
-145
-105
-315.5
-160
0
-1
0
0
0
1.2
-25.9
0
0
-36.2
-0.8
-90.8
-50.1
-60
0
0

cash-flows.row.sales-maturities-of-investments

01880.23685.43949.6
2982.1
2129
72.7
119.9
152.8
215.1
3.3
0
0
0
0
21.2
13.5
0.1
1.3
0.4
0.9
0.4
0
67.2
55.5
0
13.4

cash-flows.row.other-investing-activites

000197.9
-182.5
0.1
0
48
23.4
8.6
-0.2
42.6
0.1
0
0.1
0.2
-3.9
5.6
3.4
9
0.6
1.1
1.2
-5.1
-27.2
3.8
0.1

cash-flows.row.net-cash-used-for-investing-activites

0-182.479.4-1236.6
-658.8
-511.5
-61.5
-157.2
3.4
-140.1
-259
-21.9
-225.4
-247.5
-140.7
2.1
-298.6
-31.2
-26
-56
-297.6
-230.6
-205
21.6
-31.6
-0.4
-4.1

cash-flows.row.debt-repayment

00-30-0.8
0
-70
0
-30
-20
-625
-162.3
-230
-495
-360
-354
-524
-378
-338.9
-267.3
-415
-204.2
-255.5
-132
-18.1
-36.3
-73
-0.8

cash-flows.row.common-stock-issued

002.374.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-1.1-2.3-73.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-792.7-733.1-313.4
-163.4
-147
-135
-120.9
-123.8
-120.8
-124
-127.4
-109.5
-106.6
-101.7
-136.2
-72.5
-24.1
-44.6
-34.1
-28.6
-20
-15.9
-18.5
-3.5
-4.5
-2.6

cash-flows.row.other-financing-activites

0-9.729.4-36.1
-5.9
-70
0
10
90
20
82.8
25
1019.2
334.8
858.3
414
498.2
284
268.3
345.8
431.9
353.5
158.9
10.3
24.6
224.1
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-803.6-733.7-349.5
-163.4
-217
-135
-140.9
-53.8
-725.8
-203.4
-332.4
414.7
-131.8
402.6
-246.2
47.7
-79
-43.7
-103.3
199.1
78
11
-26.3
-15.2
146.6
-3.4

cash-flows.row.effect-of-forex-changes-on-cash

0-130.200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-38.4361.7-669
-69.7
-87.3
289.8
-173.2
647.7
-355.2
-105.7
-242.5
415.7
-211
484.1
134.2
18
43.5
-14.4
39.1
-72.2
-73.6
-99.1
36.7
74.9
124.3
-18.9

cash-flows.row.cash-at-end-of-period

01332.9550.3188.6
857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
266.8
230.2
155.2
30.9

cash-flows.row.cash-at-beginning-of-period

01371.3188.6857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
289.3
230.2
155.2
30.9
49.8

cash-flows.row.operating-cash-flow

01077.81016917
752.5
641.2
486.2
124.9
698
510.8
356.8
111.9
226.4
168.3
222.3
378.3
268.9
153.6
55.2
198.4
26.3
79
94.9
41.3
121.8
-21.9
-11.4

cash-flows.row.capital-expenditure

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.free-cash-flow

0868.9670.3728.5
570
564.8
364.9
-56.3
628
448
254.5
47.3
2
-79.3
81.4
359
248.4
142.5
24.5
133
-236.7
-152.4
-20.5
36.2
94.5
-26.2
-28.9

Tuloslaskelmarivi

Jiang Zhong Pharmaceutical Co.,Ltd liikevaihto muuttui NaN% edelliseen kauteen verrattuna. 600750.SS:n bruttovoitto ilmoitetaan NaN. Yrityksen toimintakulut ovat NaN, ja niissä on tapahtunut NaN%:n muutos edelliseen vuoteen verrattuna. Poistojen ja arvonalentumisten kulut ovat NaN, mikä on NaN% muutos edellisestä tilikaudesta. Toimintakulujen ilmoitetaan olevan NaN, mikä osoittaa NaN%:n muutoksen edellisvuoteen verrattuna. Myynti- ja markkinointikulut ovat NaN, mikä on NaN% muutos edelliseen vuoteen verrattuna. Viimeisimpiin lukuihin perustuva käyttökate on NaN, mikä vastaa NaN%:n kasvua edellisvuoteen verrattuna. Liikevoitto on NaN, joka osoittaa NaN%:n muutosta edelliseen vuoteen verrattuna. Nettotuloksen muutos on NaN%. Viime vuoden nettotulos oli NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

04327.53811.62874
2441.5
2449.4
1755.2
1746.6
1561.9
2597.4
2834.1
2777.9
3191.8
2647.3
2563.6
1890
1457.6
1168.6
1181.1
979.5
834.5
941.2
667.7
355
368.5
130.1
185
218.6
231.7
338
234.8
213.8

income-statement-row.row.cost-of-revenue

01579.613401024.9
845.5
816.8
571.4
534.4
455
1286.1
1337.7
1730.9
1983.1
1760.4
1437.9
707.3
539.5
402.9
425.8
336.4
345.2
381
284.9
219.2
186.8
97.6
155.6
193.9
204.6
288.3
193.1
165.1

income-statement-row.row.gross-profit

02747.82471.61849.1
1595.9
1632.7
1183.9
1212.2
1106.9
1311.3
1496.4
1047
1208.8
886.9
1125.7
1182.7
918.1
765.7
755.2
643.1
489.2
560.2
382.7
135.7
181.7
32.5
29.4
24.7
27.1
49.7
41.7
48.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.operating-expenses

01925.41800.21288.3
1015.3
1110.5
661.7
742.4
670.8
828.9
1083.1
848.6
921.9
629
798
893.4
716.1
606.4
624.8
543.9
408.1
448
309.5
54.2
113.6
24.7
18.2
13.9
12.5
16.8
12.9
22.7

income-statement-row.row.cost-and-expenses

035053140.22313.1
1860.8
1927.3
1233
1276.8
1125.8
2115
2420.8
2579.5
2905
2389.4
2235.9
1600.7
1255.6
1009.2
1050.6
880.2
753.4
829
594.5
273.4
300.4
122.3
173.8
207.8
217.1
16.8
206
22.7

income-statement-row.row.interest-income

067.632.326.3
15.3
17
10.4
10.8
4.5
6.1
6.4
9
8.1
7.4
1.9
1.9
3.7
0
0.7
0.8
0.6
1.1
1.2
1.8
6.5
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.total-operating-expenses

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.depreciation-and-amortization

0122.3107.479
92.2
47.5
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5
-21.1
5.6
-38.7
8.6
-41.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0822.5746.1626
573.9
567.6
548.2
483.1
445.7
430.6
329.9
202.3
267.8
276.9
310.8
245
173.8
121.1
111.9
80.4
59.3
104.2
71.8
77.6
75.6
49.8
36.1
31.9
9
21.9
20.1
18.7

income-statement-row.row.income-before-tax

0900.1751623.1
579.4
566
547.9
472.3
443.6
440.1
334.4
209.5
269.3
276.8
303.4
244.9
166.9
121.7
101
78.7
58.2
103.1
69.3
70.2
75.5
52.5
35.5
31.3
30.5
21.9
20.1
18.7

income-statement-row.row.income-tax-expense

0130.5106.892.2
89.1
86.6
77.7
54.6
63.8
72.1
67.7
36
42.5
44.8
41.6
45.7
37.4
25.6
25.3
25.8
14.6
40.3
30.6
22.5
43.8
15.1
1.9
5.2
4.6
7.2
6.6
-7.3

income-statement-row.row.net-income

0708.3598.2505.7
473.7
463.6
470.2
417.8
379.8
367
264.8
172.3
225.3
227.8
261.2
201.1
130.6
96.6
76.3
53.6
43.1
50.7
43.2
40.2
27.6
37.4
33.7
26.1
25.9
14.7
13.5
18.7
Samanlaisia osakkeita
Saatat olla myös kiinnostunut:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Usein kysytty kysymys

Mikä on Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) taseen loppusumma?

Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) kokonaisvarat ovat 6128543353.000.

Mikä on yrityksen vuotuinen liikevaihto?

Vuotuinen liikevaihto on N/A.

Mikä on yrityksen voittomarginaali?

Yrityksen voittomarginaali on 0.650.

Mikä on yrityksen vapaa kassavirta?

Vapaa kassavirta on 1.431.

Mikä on yrityksen nettovoittomarginaali?

Nettovoittomarginaali on 0.171.

Mikä on yrityksen kokonaistulot?

Kokonaisliikevaihto on 0.219.

Mikä on Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) nettovoitto (nettotulos)?

Nettovoitto (nettotulos) on 708291520.000.

Mikä on yrityksen kokonaisvelka?

Kokonaisvelka on 56623813.000.

Mikä on yrityksen toimintakulujen määrä?

Toimintakulut ovat 1925353479.000.

Mikä on yrityksen kassan määrä?

Yrityksen kassavarat ovat 0.000.